نتایج جستجو برای: pharmacogenetic

تعداد نتایج: 2484  

Journal: :Pharmacogenetics and genomics 2009
Harriet Corvol Anthony De Giacomo Celeste Eng Max Seibold Elad Ziv Rocio Chapela Jose R Rodriguez-Santana William Rodriguez-Cintron Shannon Thyne H Geoffrey Watson Kelley Meade Michael LeNoir Pedro C Avila Shweta Choudhry Esteban González Burchard

OBJECTIVE A recent admixture mapping analysis identified interleukin 6 (IL6) and IL6 receptor (IL6R) as candidate genes for inflammatory diseases. In the airways during allergic inflammation, IL6 signaling controls the production of proinflammatory and anti-inflammatory factors. In addition, albuterol, a commonly prescribed asthma therapy, has been shown to influence IL6 gene expression. Theref...

2017
Katja Goričar Viljem Kovač Vita Dolžan

Large interindividual differences in treatment outcome are observed in cancer patients undergoing chemotherapy. Our aim was to develop and validate clinical-pharmacogenetic prediction models of gemcitabine/cisplatin or pemetrexed/cisplatin treatment outcome and develop an algorithm for genotype-based treatment recommendations in malignant mesothelioma (MM). We genotyped 189 MM patients for poly...

Journal: :The Clinical journal of pain 2010
Charles E Argoff

The peer-reviewed literature yields a plethora of examples of variability in patient's responses to medications. The rapidly progressing field of pharmacogenetics offers insight into the variation in responses observed clinically, and in particular for the variability observed among patients administered mu opioid analgesics. Genetic variation leads to interperson variability in drug absorption...

Journal: :Acta medica Indonesiana 2010
Hendy Kristyanto Ahmad R Utomo

Pharmacogenetic is broadly understood as study or clinical testing of genetic variations that contribute to differing response to drugs. In cancer treatment, applications of pharmacogenetic cover three areas: avoidance of adverse drug reaction (ADR), selection of treatment options, and prediction of cancer recurrence. Patients with genetic variations in UGT1A1 and DPYD genes are hypersensitive ...

2017
Chad A. Bousman Daniel J. Müller Chee H. Ng Keith Byron Michael Berk Ajeet B. Singh

BACKGROUND Pharmacogenetic-based dosing support tools have been developed to personalize antidepressant-prescribing practice. However, the clinical validity of these tools has not been adequately tested, particularly for specific antidepressants. OBJECTIVE To examine the concordance between the actual dose and a polygene pharmacogenetic predicted dose of desvenlafaxine needed to achieve sympt...

Journal: :Epidemiologia e prevenzione 2015
Elvira D'Andrea Carolina Marzuillo Ferruccio Pelone Corrado De Vito Paolo Villari

OBJECTIVES To identify those studies in which economic analysis of predictive genetic and pharmacogenetic testing programs have been carried out. Since the Italian National Prevention Plan 2014-2018 foresees the implementation of genetic testing for inherited breast cancer, special attention was given to the cost-effectiveness of BRCA1/2 testing programs. METHODS A systematic review of primar...

Journal: :Clinical pharmacology and therapeutics 2010
P Lenzini M Wadelius S Kimmel J L Anderson A L Jorgensen M Pirmohamed M D Caldwell N Limdi J K Burmester M B Dowd P Angchaisuksiri A R Bass J Chen N Eriksson A Rane J D Lindh J F Carlquist B D Horne G Grice P E Milligan C Eby J Shin H Kim D Kurnik C M Stein G McMillin R C Pendleton R L Berg P Deloukas B F Gage

Well-characterized genes that affect warfarin metabolism (cytochrome P450 (CYP) 2C9) and sensitivity (vitamin K epoxide reductase complex 1 (VKORC1)) explain one-third of the variability in therapeutic dose before the international normalized ratio (INR) is measured. To determine genotypic relevance after INR becomes available, we derived clinical and pharmacogenetic refinement algorithms on th...

2015
Victor E Ortega Deborah A Meyers Eugene R Bleecker

Human genetics research will be critical to the development of genetic profiles for personalized or precision medicine in asthma. Genetic profiles will consist of gene variants that predict individual disease susceptibility and risk for progression, predict which pharmacologic therapies will result in a maximal therapeutic benefit, and predict whether a therapy will result in an adverse respons...

Journal: :Human molecular genetics 2014
Adam S Gordon Holly K Tabor Andrew D Johnson Beverly M Snively Themistocles L Assimes Paul L Auer John P A Ioannidis Ulrike Peters Jennifer G Robinson Lara E Sucheston Danxin Wang Nona Sotoodehnia Jerome I Rotter Bruce M Psaty Rebecca D Jackson David M Herrington Christopher J O'Donnell Alexander P Reiner Stephen S Rich Mark J Rieder Michael J Bamshad Deborah A Nickerson

The study of genetic influences on drug response and efficacy ('pharmacogenetics') has existed for over 50 years. Yet, we still lack a complete picture of how genetic variation, both common and rare, affects each individual's responses to medications. Exome sequencing is a promising alternative method for pharmacogenetic discovery as it provides information on both common and rare variation in ...

Journal: :Cancer treatment reviews 2015
C N Frederiks S W Lam H J Guchelaar E Boven

BACKGROUND Taxanes, including paclitaxel and docetaxel, are indispensable for treatment of cancer. Development of toxicity frequently necessitates dose reduction or discontinuation of therapy, despite clinical response. OBJECTIVE Pharmacogenetic studies were reviewed for identification of genetic variants possibly underlying individual susceptibility to adverse events. METHOD We conducted a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید